Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa

Kura Oncology positions Darlifarnib as foundational combination platform following strong Phase 1a results

Kura Oncology (NASDAQ:KURA) has released preliminary Phase 1a data showcasing the potential of its next-generation farnesyl transferase inhibitor (FTI), darlifarnib, as a foundational component of combination therapies for KRAS-mutant cancers.

Read more: Kura Oncology positions Darlifarnib as foundational combination platform following strong Phase 1a results